Age-Related Differences in Claims-Coded Coronary Artery Abnormalities and Antithrombotic Management in Kawasaki Disease: A Nationwide Claims-Based Study in Korea

Background/Objectives: Younger age is an established risk factor for coronary artery abnormalities (CAAs) in Kawasaki disease (KD), but nationwide data on age-related differences in treatment and antithrombotic management are limited. We characterized age-specific patterns of claims-coded CAAs, initial treatment, and antithrombotic prescribing in Korean children with KD. Methods: Using the Health Insurance Review and Assessment Service database, we analyzed 52,247 patients with KD diagnosed in 2010–2023, stratified by age (<1, 1 to <5, and 5 to <18 years). CAAs were identified by diagnostic code I25.4, which does not distinguish aneurysm from ectasia. Factors associated with claims-coded CAAs were explored using multivariable logistic regression. Results: Claims-coded CAAs were identified in 3.3% of patients, with similar proportions across age groups (3.5%, 3.1%, and 3.5%; p = 0.069). Older children (≥5 years) more frequently received initial intravenous immunoglobulin (IVIG) plus corticosteroid therapy (24.3% vs. 16.0–18.5%; p < 0.001). Among patients with claims-coded CAAs, older children more often had cumulative, not necessarily concurrent, exposure to aspirin, clopidogrel, and warfarin during follow-up (10.8% vs. 3.7–6.2%) and antithrombotic prescriptions for >12 months (40.6% vs. 25.3–25.6%). IVIG prescription on hospital Day ≥ 3 was associated with higher odds of claims-coded CAAs (adjusted odds ratio, 1.48; 95% confidence interval, 1.22–1.80). Conclusions: Although the proportion of claims-coded CAAs was similar across age groups, recorded antithrombotic prescribing among affected children differed by age; because observation time was not standardized, whether this reflects true management differences or lesion severity requires validation. KD should remain in the differential diagnosis for school-age children.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-12
DOI
https://doi.org/10.3390/jcm15228864
Primary Topic
Kawasaki Disease and Coronary Complications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Age-Related Differences in Claims-Coded Coronary Artery Abnormalities and Antithrombotic Management in Kawasaki Disease: A Nationwide Claims-Based Study in Korea

Youngjin Jung, Jae Min Lee, Young Tae Lim, Hanpyo Hong et al.
Journal of Clinical Medicine
Kawasaki Disease and Coronary Complications
article

Age-Related Differences in Claims-Coded Coronary Artery Abnormalities and Antithrombotic Management in Kawasaki Disease: A Nationwide Claims-Based Study in Korea

Youngjin Jung, Jae Min Lee, Young Tae Lim, Hanpyo Hong, Hye Won Kim
article en

Abstract

Background/Objectives: Younger age is an established risk factor for coronary artery abnormalities (CAAs) in Kawasaki disease (KD), but nationwide data on age-related differences in treatment and antithrombotic management are limited. We characterized age-specific patterns of claims-coded CAAs, initial treatment, and antithrombotic prescribing in Korean children with KD. Methods: Using the Health Insurance Review and Assessment Service database, we analyzed 52,247 patients with KD diagnosed in 2010–2023, stratified by age (<1, 1 to <5, and 5 to <18 years). CAAs were identified by diagnostic code I25.4, which does not distinguish aneurysm from ectasia. Factors associated with claims-coded CAAs were explored using multivariable logistic regression. Results: Claims-coded CAAs were identified in 3.3% of patients, with similar proportions across age groups (3.5%, 3.1%, and 3.5%; p = 0.069). Older children (≥5 years) more frequently received initial intravenous immunoglobulin (IVIG) plus corticosteroid therapy (24.3% vs. 16.0–18.5%; p < 0.001). Among patients with claims-coded CAAs, older children more often had cumulative, not necessarily concurrent, exposure to aspirin, clopidogrel, and warfarin during follow-up (10.8% vs. 3.7–6.2%) and antithrombotic prescriptions for >12 months (40.6% vs. 25.3–25.6%). IVIG prescription on hospital Day ≥ 3 was associated with higher odds of claims-coded CAAs (adjusted odds ratio, 1.48; 95% confidence interval, 1.22–1.80). Conclusions: Although the proportion of claims-coded CAAs was similar across age groups, recorded antithrombotic prescribing among affected children differed by age; because observation time was not standardized, whether this reflects true management differences or lesion severity requires validation. KD should remain in the differential diagnosis for school-age children.

Journal of Clinical MedicineVol. 15(22)
Kyungpook National University (KR), Pusan National University Yangsan Hospital (KR), Yeungnam University Medical Center (KR), Pusan National University Children's Hospital (KR), Pusan National University (KR)
Yeungnam University
Good health and well-being
Kawasaki Disease and Coronary Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon